{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:25:43Z","timestamp":1792481143127,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008770","name":"Anadolu University","doi-asserted-by":"publisher","award":["1610S681"],"award-info":[{"award-number":["1610S681"]}],"id":[{"id":"10.13039\/501100008770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["315S103"],"award-info":[{"award-number":["315S103"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bioorg.2020.103897","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T21:17:07Z","timestamp":1588540627000},"page":"103897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":169,"special_numbering":"C","title":["Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, \u03b1-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs"],"prefix":"10.1016","volume":"100","author":[{"given":"Nebih","family":"Lolak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcleyman","family":"Akocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00fcneyt","family":"T\u00fcrke\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Taslimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e\u00fckr\u00fc","family":"Beydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lhami","family":"G\u00fcl\u00e7in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Durgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.103897_b0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3109\/14756366.2015.1054820","article-title":"The effects of some bromophenols on human carbonic anhydrase isoenzymes","volume":"31","author":"Taslimi","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0010","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3109\/14756366.2016.1149479","article-title":"Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase","volume":"31","author":"Ozgun","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0015","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1021\/acs.jmedchem.6b00492","article-title":"PEGylated bis-sulfonamide carbonic anhydrase inhibitors can efficiently control the growth of several carbonic anhydrase IX-expressing carcinomas","volume":"59","author":"Akocak","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0020","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3109\/14756366.2016.1156104","article-title":"Synthesis of some tetrahydropyrimidine-5-carboxylates, determination of their metal chelating effects and inhibition profiles against acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase","volume":"31","author":"Sujayev","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0025","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3109\/14756366.2016.1160077","article-title":"Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a, 4-dihydro-3 H-indeno [1, 2-c] pyrazol-2-yl) benzenesulfonamides","volume":"31","author":"Gul","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/14756366.2016.1189422","article-title":"Synthesis of diaryl ethers with acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase inhibitory actions","volume":"31","author":"\u00d6zbey","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756366.2016.1198901","article-title":"Synthesis of 4, 5-disubstituted-2-thioxo-1, 2, 3, 4-tetrahydropyrimidines and investigation of their acetylcholinesterase, butyrylcholinesterase, carbonic anhydrase I\/II inhibitory and antioxidant activities","volume":"31","author":"Garibov","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0040","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ardp.201600183","article-title":"Antioxidant activity, acetylcholinesterase, and carbonic anhydrase inhibitory properties of novel ureas derived from phenethylamines","volume":"349","author":"Aksu","year":"2016","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2020.103897_b0045","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1080\/14756366.2019.1664501","article-title":"Activation of \u03b1-, \u03b2-, \u03b3-\u03b4-, \u03b6-and \u03b7-class of carbonic anhydrases with amines and amino acids: a review","volume":"34","author":"Akocak","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bioorg.2018.01.022","article-title":"Synthesis and biological evaluation of novel N, N\u2032-diaryl cyanoguanidines acting as potent and selective carbonic anhydrase II inhibitors","volume":"77","author":"Akocak","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bioorg.2018.12.035","article-title":"Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and \u03b1-glycosidase inhibitors","volume":"85","author":"Burmaoglu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1350-9462(99)00006-3","article-title":"Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors","volume":"19","author":"Sugrue","year":"2000","journal-title":"Progress in retinal and eye research"},{"key":"10.1016\/j.bioorg.2020.103897_b0065","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3109\/14756366.2015.1113172","article-title":"Synthesis of N-alkyl (aril)-tetra pyrimidine thiones and investigation of their human carbonic anhydrase I and II inhibitory effects","volume":"31","author":"Sujayev","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0070","doi-asserted-by":"crossref","unstructured":"M. Topal, \u0130. G\u00dcL\u00c7\u0130N, Rosmarinic acid: a potent carbonic anhydrase isoenzymes inhibitor, Turkish journal of chemistry, 38 (2014) 894-902. https:\/\/doi.org\/10.3906\/kim-1403-5.","DOI":"10.3906\/kim-1403-5"},{"key":"10.1016\/j.bioorg.2020.103897_b0075","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.bmc.2013.01.019","article-title":"Novel sulfamides as potential carbonic anhydrase isoenzymes inhibitors","volume":"21","author":"Ak\u0131nc\u0131o\u011flu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0080","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0085","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10528-007-9086-x","article-title":"Decreased total carbonic anhydrase esterase activity and decreased levels of carbonic anhydrase 1 isozyme in erythrocytes of type II diabetic patients","volume":"45","author":"Gambhir","year":"2007","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.bioorg.2020.103897_b0090","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s10528-009-9231-9","article-title":"Erythrocyte total carbonic anhydrase esterase activity in African American obese children: reduction starts at a young age","volume":"47","author":"Malheiro","year":"2009","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.bioorg.2020.103897_b0095","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.bioorg.2020.103897_b0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jphotobiol.2016.07.014","article-title":"Fluorescein dye derivatives and their nanohybrids: synthesis, characterization and antimicrobial activity","volume":"162","author":"Negm","year":"2016","journal-title":"J. Photochem. Photobiol., B"},{"key":"10.1016\/j.bioorg.2020.103897_b0105","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21872","article-title":"Synthesis, carbonic anhydrase I and II isoenzymes inhibition properties, and antibacterial activities of novel tetralone-based 1, 4-benzothiazepine derivatives","volume":"31","author":"Ceylan","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2020.103897_b0110","first-page":"3093","article-title":"Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I","volume":"25","author":"Akocak","year":"2017","journal-title":"II, VII and IX inhibitors, Bioorganic & medicinal chemistry"},{"key":"10.1016\/j.bioorg.2020.103897_b0115","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21956","article-title":"Antidiabetic potential: In vitro inhibition effects of some natural phenolic compounds on \u03b1-glycosidase and \u03b1-amylase enzymes","volume":"31","author":"Taslimi","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2020.103897_b0120","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1080\/10942912.2019.1656234","article-title":"The inhibition profile of sesamol against \u03b1-glycosidase and acetylcholinesterase enzymes","volume":"22","author":"Topal","year":"2019","journal-title":"Int. J. Food Prop."},{"key":"10.1016\/j.bioorg.2020.103897_b0125","doi-asserted-by":"crossref","first-page":"1700314","DOI":"10.1002\/ardp.201700314","article-title":"Synthesis and biological evaluation of phloroglucinol derivatives possessing \u03b1-glycosidase, acetylcholinesterase, butyrylcholinesterase, carbonic anhydrase inhibitory activity","volume":"351","author":"Burmaoglu","year":"2018","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2020.103897_b0130","article-title":"Synthesis and discovery of potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase, and \u03b1-glycosidase enzymes inhibitors: The novel N, N\u2032-bis-cyanomethylamine and alkoxymethylamine derivatives","volume":"32","author":"Taslimi","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2020.103897_b0135","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/35067589","article-title":"Acetylcholinesterase\u2014new roles for an old actor","volume":"2","author":"Soreq","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bioorg.2020.103897_b0140","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/10942912.2019.1597882","article-title":"Anticholinergic and antidiabetic effects of isoeugenol from clove (Eugenia caryophylata) oil","volume":"22","author":"Topal","year":"2019","journal-title":"Int. J. Food Prop."},{"key":"10.1016\/j.bioorg.2020.103897_b0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/13813455.2015.1026912","article-title":"Changes in the anti-oxidant system in adult epilepsy patients receiving anti-epileptic drugs","volume":"121","author":"I\u015f\u0131k","year":"2015","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.bioorg.2020.103897_b0150","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.biopha.2017.01.003","article-title":"Oxidative stress and mRNA expression of acetylcholinesterase in the leukocytes of ischemic patients","volume":"87","author":"I\u015f\u0131k","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2020.103897_b0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.18596\/jotcsa.516444","article-title":"Design, synthesis and biological evaluation of 1, 3-diaryltriazene-substituted sulfonamides as antioxidant, acetylcholinesterase and butyrylcholinesterase inhibitors","volume":"6","author":"Akocak","year":"2019","journal-title":"Journal of the Turkish Chemical Society, Section A: Chemistry"},{"key":"10.1016\/j.bioorg.2020.103897_b0160","first-page":"1","article-title":"AChE mRNA expression as a possible novel biomarker for the diagnosis of coronary artery disease and Alzheimer\u2019s disease, and its association with oxidative stress","author":"I\u015f\u0131k","year":"2019","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.bioorg.2020.103897_b0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.25135\/rnp.155.19.06.1326","article-title":"Secondary Metabolites of Ethanol Extracts of Pinus sylvestris Cones from Eastern Anatolia and Their Antioxidant","volume":"14","author":"Topal","year":"2019","journal-title":"Cholinesterase and \u03b1-Glucosidase Activities, Records Natural Products"},{"key":"10.1016\/j.bioorg.2020.103897_b0170","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.bioorg.2020.103897_b0175","first-page":"34","article-title":"Next-generation primary sulfonamide carbonic ahydrase inhibitors, in Targeting Carbonic Anhydrases","author":"Akocak","year":"2014","journal-title":"Future Science"},{"key":"10.1016\/j.bioorg.2020.103897_b0180","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureiod-Substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0185","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1080\/14756366.2018.1515933","article-title":"Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors","volume":"33","author":"Akocak","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0190","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bioorg.2018.02.015","article-title":"Design and synthesis of novel 1,3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors","volume":"77","author":"Lolak","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bioorg.2018.10.005","article-title":"Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1, 3, 5-triazine moieties as potent carbonic anhydrase IX inhibitors","volume":"82","author":"Lolak","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0200","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bmc.2019.03.001","article-title":"Discovery of new ureido benzenesulfonamides incorporating 1, 3, 5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors","volume":"27","author":"Lolak","year":"2019","journal-title":"Bioorg. Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2020.103897_b0205","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/molecules23071616","article-title":"Hybrid Molecules Composed of 2, 4-Diamino-1, 3, 5-triazines and 2-Imino-Coumarins and Coumarins Synthesis and Cytotoxic Properties","volume":"23","author":"Makowska","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2020.103897_b0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2016.03.088","article-title":"Synthesis and in vitro evaluation of novel triazine analogues as anticancer agents and their interaction studies with bovine serum albumin","volume":"117","author":"Singla","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0215","doi-asserted-by":"crossref","unstructured":"R. V Patel, Y.-S. Keum, S. Won Park, Medicinal chemistry discoveries among 1, 3, 5-triazines: recent advances (2000-2013) as antimicrobial, anti-TB, anti-HIV and antimalarials, Mini reviews in medicinal chemistry, 14 (2014) 768-789.","DOI":"10.2174\/1389557514666140622205904"},{"key":"10.1016\/j.bioorg.2020.103897_b0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bioorg.2017.12.034","article-title":"Novel sulfonamide incorporating piperazine, aminoalcohol and 1, 3, 5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action","volume":"77","author":"Havr\u00e1nkov\u00e1","year":"2018","journal-title":"Bioorganic chemistry"},{"key":"10.1016\/j.bioorg.2020.103897_b0225","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bioorg.2018.08.005","article-title":"Novel sulfonamides incorporating 1, 3, 5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX","volume":"81","author":"Miku\u0161","year":"2018","journal-title":"Bioorganic chemistry"},{"key":"10.1016\/j.bioorg.2020.103897_b0230","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1016\/j.bmc.2013.09.031","article-title":"Inhibition of human carbonic anhydrase isoforms I-XIV with sulfonamides incorporating fluorine and 1, 3, 5-triazine moieties","volume":"21","author":"Ceruso","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0235","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/14756366.2019.1707196","article-title":"Sulphonamides incorporating 1, 3, 5-triazine structural motifs show antioxidant, acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibitory profile","volume":"35","author":"Lolak","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0240","first-page":"408","article-title":"Phenolic compounds as antioxidants: carbonic anhydrase isoenzymes inhibitors","volume":"13","author":"Gulcin","year":"2013","journal-title":"Mini reviews in medicinal chemistry"},{"key":"10.1016\/j.bioorg.2020.103897_b0245","doi-asserted-by":"crossref","unstructured":"E. Hoff, D. Zou, S. Schiza, Y. Demir, L. Grote, I. Bouloukaki, \u015e. Beydemir, D. Eskandari, K. Stenl\u00f6f, J. Hedner, Carbonic anhydrase, obstructive sleep apnea and hypertension: Effects of intervention, Journal of Sleep Research, (2019) e12956. https:\/\/doi.org\/10.1111\/jsr.12956.","DOI":"10.1111\/jsr.12956"},{"key":"10.1016\/j.bioorg.2020.103897_b0250","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s11064-019-02852-y","article-title":"The binding mechanisms and inhibitory effect of intravenous anesthetics on AChE in vitro and in vivo: kinetic analysis and molecular docking","volume":"44","author":"I\u015f\u0131k","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bioorg.2020.103897_b0255","doi-asserted-by":"crossref","first-page":"221","DOI":"10.38001\/ijlsb.636502","article-title":"Bioactivities of Hypericum Perforatum L and Equisetum Arvense L fractions obtained with different solvents","volume":"2","author":"Necip","year":"2019","journal-title":"International J. Life Sciences Biotechnology"},{"key":"10.1016\/j.bioorg.2020.103897_b0260","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14756366.2016.1244533","article-title":"Synthesis, carbonic anhydrase I and II inhibition studies of the 1, 3, 5-trisubstituted-pyrazolines","volume":"32","author":"Gul","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0265","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21930","article-title":"Inhibition properties of some flavonoids on carbonic anhydrase I and II isoenzymes purified from human erythrocytes","volume":"31","author":"Huyut","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2020.103897_b0270","doi-asserted-by":"crossref","unstructured":"M. Durgun, C. Turkes, M. Isik, Y. Demir, A. Sakli, A. Kuru, A. Guzel. S. Beydemir, S. Akocak, S.M. Osman, Z. AlOhman, C.T.Supuran, Synthesis, characterisation, biological evaluation and in silico studies of sulphonamide Schiff bases, Journal of enzyme inhibition and medicinal chemistry, 35 (2020) 950-962. https:\/\/doi.org\/10.1080\/14756366.2020.1746784.","DOI":"10.1080\/14756366.2020.1746784"},{"key":"10.1016\/j.bioorg.2020.103897_b0275","first-page":"580","article-title":"Some drugs inhibit in vitro hydratase and esterase activities of human carbonic anhydrase-I and II","volume":"59","author":"Ekinci","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bioorg.2020.103897_b0280","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/14756366.2011.651465","article-title":"Inhibitory effect of novel pyrazole carboxamide derivatives on human carbonic anhydrase enzyme","volume":"28","author":"\u015een","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0285","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103897_b0290","first-page":"1","article-title":"Investigation of the effects of cephalosporin antibiotics on glutathione S-transferase activity in different tissues of rats in vivo conditions in order to drug development research","author":"T\u00fcrkan","year":"2018","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.bioorg.2020.103897_b0295","doi-asserted-by":"crossref","first-page":"1800263","DOI":"10.1002\/ardp.201800263","article-title":"Antidiabetic potential: in vitro inhibition effects of bromophenol and diarylmethanones derivatives on metabolic enzymes","volume":"351","author":"Demir","year":"2018","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2020.103897_b0300","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3109\/14756366.2012.715287","article-title":"Synthesis and paroxonase activities of novel bromophenols","volume":"28","author":"Akbaba","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0305","first-page":"10","article-title":"Inhibition Effects of Gemcitabine Hydrochloride, Acyclovir, and 5-Fluorouracil on Human Serum Paraoxonase-1 (hPON1)","volume":"1","author":"T\u00fcrke\u015f","year":"2013","journal-title":"Vitro, Open Journal of Biochemistry"},{"key":"10.1016\/j.bioorg.2020.103897_b0310","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharep.2013.08.007","article-title":"Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress","volume":"66","author":"T\u00fcrke\u015f","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bioorg.2020.103897_b0315","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/14756366.2014.959511","article-title":"Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium","volume":"30","author":"T\u00fcrke\u015f","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0320","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21935","article-title":"Phenolic compounds inhibit the aldose reductase enzyme from the sheep kidney","volume":"31","author":"Demir","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2020.103897_b0325","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.etap.2015.11.024","article-title":"In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum","volume":"42","author":"T\u00fcrke\u015f","year":"2016","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103897_b0330","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12010-019-03009-x","article-title":"Anti-diabetic properties of calcium channel blockers: inhibition effects on aldose reductase enzyme activity","volume":"189","author":"T\u00fcrke\u015f","year":"2019","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.bioorg.2020.103897_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103004","article-title":"Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors","volume":"89","author":"T\u00fcrke\u015f","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2020.103897_b0345","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1021\/ja993663t","article-title":"Prediction of properties from simulations: free energies of solvation in hexadecane, octanol, and water","volume":"122","author":"Duffy","year":"2000","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.103897_b0350","doi-asserted-by":"crossref","first-page":"13347","DOI":"10.1002\/slct.201903458","article-title":"New Isoindole 1, 3-dione Substituted Sulfonamides as Potent Inhibitors of Carbonic Anhydrase and Acetylcholinesterase: Design Synthesis, and Biological Evaluation","volume":"4","author":"G\u00fcndo\u011fdu","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2020.103897_b0355","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1002\/slct.201902424","article-title":"In vitro and in silico studies on the toxic effects of antibacterial drugs as human serum paraoxonase 1 inhibitor","volume":"4","author":"T\u00fcrke\u015f","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2020.103897_b0360","first-page":"1","article-title":"Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies","author":"Beydemir","year":"2019","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.bioorg.2020.103897_b0365","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/0929866526666190226162225","article-title":"Investigation of potential paraoxonase-I inhibitors by kinetic and molecular docking studies: chemotherapeutic drugs","volume":"26","author":"T\u00fcrke\u015f","year":"2019","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bioorg.2020.103897_b0370","first-page":"1","article-title":"Molecular docking and investigation of 4-(benzylideneamino)-and 4-(benzylamino)-benzenesulfonamide derivatives as potent AChE inhibitors","author":"I\u015f\u0131k","year":"2019","journal-title":"Chem. Pap."},{"key":"10.1016\/j.bioorg.2020.103897_b0375","first-page":"1013","article-title":"Inhibition effects of phenolic compounds on human serum paraoxonase-1 enzyme","volume":"9","author":"T\u00fcrke\u015f","year":"2019","journal-title":"J. Institute of Science and Technology"},{"key":"10.1016\/j.bioorg.2020.103897_b0380","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12010-019-03073-3","article-title":"Inhibition of human serum paraoxonase-I with antimycotic drugs: in vitro and in silico studies","volume":"190","author":"T\u00fcrke\u015f","year":"2020","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.bioorg.2020.103897_b0385","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ijbiomac.2019.09.237","article-title":"Benzenesulfonamide derivatives containing imine and amine groups: Inhibition on human paraoxonase and molecular docking studies","volume":"146","author":"I\u015f\u0131k","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2020.103897_b0390","doi-asserted-by":"crossref","DOI":"10.2174\/1871520620666200218110645","article-title":"Molecular Docking Studies and Inhibition Properties of Some Antineoplastic Agents against Paraoxonase-I","author":"Demir","year":"2020","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103897_b0395","first-page":"1","article-title":"Calcium Channel Blockers: Molecular Docking and Inhibition Studies on Carbonic Anhydrase I and II Isoenzymes","author":"T\u00fcrke\u015f","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2020.103897_b0400","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/jphp.13141","article-title":"A potential risk factor for paraoxonase 1: in silico and in vitro analysis of the biological activity of proton-pump inhibitors","volume":"71","author":"T\u00fcrke\u015f","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103897_b0405","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900383","article-title":"Sulfonamides incorporating ketene N, S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors","author":"Istrefi","year":"2020","journal-title":"Arch. Pharm."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820306325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820306325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:03:40Z","timestamp":1758614620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820306325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":81,"alternative-id":["S0045206820306325"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103897","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, \u03b1-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103897"}}